According to the aforementioned results, the active components in Guishao-Liujun decoction have effective binding activities with IL-17, TP53, AKT1, and TNF, but further validation is required for the bio-functionality of its compounds for the treatment of GC. This evidence concerns the gene TP53 and gastric cancer.